Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Villunger

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|February 8, 1996
Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategiesA Villunger, A Egle, M Kos, et al.
Oncogene|March 21, 2012
Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and BmfF Baumgartner, C Woess, V Pedit, et al.
Molecular Endocrinology (Baltimore, Md.)|November 1, 1991
Lactogenic hormone and cell type-specific control of the whey acidic protein gene promoter in transfected mouse cellsW Doppler, A Villunger, P Jennewein, et al.
The Analyst|August 4, 2015
Application of mid-infrared (MIR) microscopy imaging for discrimination between follicular hyperplasia and follicular lymphoma in transgenic miceC Woess, M Drach, A Villunger, et al.
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Leukemia|November 30, 2007
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemiaC Ploner, J Rainer, H Niederegger, et al.
Cell Death and Differentiation|February 21, 2015
Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic miceC Woess, S Tuzlak, V Labi, et al.
Oncogene|October 4, 2016
MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesisM Sochalska, F Schuler, J G Weiss, et al.
Blood|May 30, 1998
Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemiaI Tinhofer, I Marschitz, M Kos, et al.
Cell Death and Differentiation|July 4, 2015
MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cellsU Knackmuss, S E Lindner, T Aneichyk, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|February 8, 1996
Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategiesA Villunger, A Egle, M Kos, et al.
Oncogene|March 21, 2012
Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and BmfF Baumgartner, C Woess, V Pedit, et al.
Molecular Endocrinology (Baltimore, Md.)|November 1, 1991
Lactogenic hormone and cell type-specific control of the whey acidic protein gene promoter in transfected mouse cellsW Doppler, A Villunger, P Jennewein, et al.
The Analyst|August 4, 2015
Application of mid-infrared (MIR) microscopy imaging for discrimination between follicular hyperplasia and follicular lymphoma in transgenic miceC Woess, M Drach, A Villunger, et al.
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Leukemia|November 30, 2007
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemiaC Ploner, J Rainer, H Niederegger, et al.
Cell Death and Differentiation|February 21, 2015
Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic miceC Woess, S Tuzlak, V Labi, et al.
Oncogene|October 4, 2016
MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesisM Sochalska, F Schuler, J G Weiss, et al.
Blood|May 30, 1998
Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemiaI Tinhofer, I Marschitz, M Kos, et al.
Cell Death and Differentiation|July 4, 2015
MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cellsU Knackmuss, S E Lindner, T Aneichyk, et al.
Pageof 6